← All organizations

Celimmune

For profit

Phase 1 Phase 2 Phase 3 Phase 4

Highest phase reached

Phase 2

First clinical trial

Last known activity

Mar 1, 2016

Acquired by Amgen on Jun 1, 2017

Timeline

2010s

Jun 1, 2015
Celimmune— Founded
Jun 1, 2017
Amgen— Acquired By

Drugs by trial phase (1 distinct, 2 trials)

Phase 2 (1 own, 0 via acquisition)

prv-015

Indications

Studied for

Recent trials (2)

NCT02633020Lead sponsorPhase 2Mar 1, 2016
NCT02637141Lead sponsorPhase 2Mar 1, 2016

Details

Founded: Bethesda, MD, US Jun 1, 2015
Last known activity: Mar 1, 2016